Investigation of the riddle of sulfathiazole polymorphism.

Since the discovery of sulfathiazole as an antimicrobial agent in 1939, numerous works in the screening for its different polymorphic forms, which is an essential part of drug development, have been conducted and published. These works consequently result in the availability of various methods for generating a particular polymorph. By following these methods, however, one cannot be guaranteed to obtain the intended pure polymorph because most of the methods do not clearly and adequately describe the crystallisation conditions, such as cooling rates and initial solute concentrations. In this paper, the available methods for generating all the known polymorphs of sulfathiazole are reviewed and selected methods for generating certain polymorphs, performed with their processes monitored using process analytical technology tools, i.e. focussed beam reflectance measurement and attenuated total reflectance ultraviolet spectroscopy, are presented. The properties of the obtained crystals, examined using various characterisation methods, are also presented and whenever possible, are compared with those of other workers.

[1]  Jukka Rantanen,et al.  DRIFT-IR for quantitative characterization of polymorphic composition of sulfathiazole , 2005 .

[2]  Lawrence X. Yu,et al.  Applications of process analytical technology to crystallization processes. , 2004, Advanced drug delivery reviews.

[3]  V. Boldyrev,et al.  Phase Transformations in Sulfathiazole During Mechanical Activation , 1993 .

[4]  Kati Pöllänen,et al.  Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition , 2005, Biotechnology and applied biochemistry.

[5]  Michael B. Hursthouse,et al.  Packing similarity in polymorphs of sulfathiazole , 2008 .

[6]  J. Rantanen,et al.  Characterization of polymorphic solid-state changes using variable temperature X-ray powder diffraction. , 2005, Journal of pharmaceutical and biomedical analysis.

[7]  J. E. Carless,et al.  The thermodynamic properties of sulphathiazole , 1974 .

[8]  R. S. Payne,et al.  Crystal chemistry and solvent effects in polymorphic systems Sulfathiazole , 1998 .

[9]  Pascal Billot,et al.  Application of ATR-UV Spectroscopy for Monitoring the Crystallisation of UV Absorbing and Nonabsorbing Molecules , 2010 .

[10]  Z. Nagy,et al.  Seeded Batch Cooling Crystallization with Temperature Cycling for the Control of Size Uniformity and Polymorphic Purity of Sulfathiazole Crystals , 2009 .

[11]  R. Mesley The polymorphism of sulphathiazole , 1971, The Journal of pharmacy and pharmacology.

[12]  R. Mesley,et al.  Infrared identification of pharmaceutically important sulphonamides with particular reference to the occurrence of polymorphism , 1967 .

[13]  R. Cernik,et al.  Ab initio structure determination of sulfathiazole polymorph V from synchrotron X-ray powder diffraction data , 1999 .

[14]  H. Wu,et al.  Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development. , 2011, International journal of pharmaceutics.

[15]  L. J. Ravin,et al.  Kinetics of polymorphic transformation of sulfathiazole form I. , 1972, Journal of pharmaceutical sciences.

[16]  E. Boldyreva,et al.  Crystal structures of sulfathiazole polymorphs in the temperature range 100–295 K: A comparative analysis , 2008 .

[17]  W. A. Lott,et al.  2-(p-AMINOBENZENESULFONAMIDO)-THIAZOLE: A NEW CHEMOTHERAPEUTIC AGENT , 1939 .

[18]  L. S. Shenouda Various species of sulfathiazole form I. , 1970, Journal of pharmaceutical sciences.

[19]  Michael B. Hursthouse,et al.  A new polymorph of sulfathiazole , 1999 .

[20]  Zoltan K. Nagy,et al.  A Process Analytical Technology Based Investigation of the Polymorphic Transformations during the Antisolvent Crystallization of Sodium Benzoate from IPA/Water Mixture , 2009 .

[21]  H. Brunner,et al.  Synthesis and gas permeation properties of an NaA zeolite membrane , 2000 .

[22]  James L. Ford,et al.  Polymorph Selection with Morphology Control Using Solvents , 2007 .

[23]  Thomas Rades,et al.  Characterization of temperature-induced phase transitions in five polymorphic forms of sulfathiazole by terahertz pulsed spectroscopy and differential scanning calorimetry. , 2006, Journal of pharmaceutical sciences.

[24]  J. Guillory Heats of transition of methylprednisolone and sulfathiazole by a differential thermal analysis method. , 1967, Journal of pharmaceutical sciences.

[25]  G. Kruger,et al.  The crystal structures of polymorphs I and III of sulphathiazole , 1972 .

[26]  C. Lerk,et al.  The polymorphism of sulphathiazole , 1981 .

[27]  Howell G. M. Edwards,et al.  Insight into thermally induced solid-state polymorphic transformation of sulfathiazole using simultaneous in situ Raman spectroscopy and differential scanning calorimetry , 2009 .

[28]  M. Kemper,et al.  Quantifying Crystalline Form Composition in Binary Powder Mixtures Using Near-Infrared Reflectance Spectroscopy , 2000, Pharmaceutical development and technology.

[29]  A. Domínguez-Gil,et al.  Determination of the macro- and micro-ionization constants of a dipolar zwitterionic cephalosporin: Cefadroxil , 1981 .

[30]  W. Higuchi,et al.  Polymorphism and drug availability. II. Dissolution rate behavior of the polymorphic forms of sulfathiazole and methylprednisolone. , 1967, Journal of pharmaceutical sciences.

[31]  G. Milosovich DETERMINATION OF SOLUBILITY OF A METASTABLE POLYMORPH. , 1964, Journal of pharmaceutical sciences.

[32]  J. Anderson,et al.  Determination of the onset of crystallization of N1-2-(thiazolyl)sulfanilamide (sulfathiazole) by UV-Vis and calorimetry using an automated reaction platform; subsequent characterization of polymorphic forms using dispersive Raman spectroscopy. , 2001, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[34]  J. Anwar,et al.  Polymorphism of sulfathiazole. , 1989, Journal of pharmaceutical sciences.

[35]  G. Kruger,et al.  The crystal structure of sulphathiazole II , 1971 .

[36]  R. Miller,et al.  A hot stage microscope incorporating a differential thermal analysis unit , 1966 .

[37]  Jukka Rantanen,et al.  Polymorph screening using near-infrared spectroscopy , 2003 .

[38]  J. Anwar,et al.  Crystallization of polymorphs : the effect of solvent , 1993 .

[39]  A. Myerson Handbook of Industrial Crystallization , 2002 .

[40]  R. J. Fosbinder,et al.  Sulfanilamido Derivatives of Heterocyclic Amines , 1939 .

[41]  S. Tavener,et al.  Sulfathiazole polymorphism studied by magic-angle spinning NMR. , 1999, Journal of pharmaceutical sciences.

[42]  D. Fox Physics and Chemistry of the Organic Solid State , 1963 .

[43]  J. E. Carless,et al.  Application of differential scanning calorimetry to the study of sulphathiazole crystal forms , 1969, The Journal of pharmacy and pharmacology.

[44]  J. E. Carless,et al.  The crystallization behaviour of sulphathiazole , 1976, The Journal of pharmacy and pharmacology.

[45]  L. L. Simon,et al.  Comparison of external bulk video imaging with focused beam reflectance measurement and ultra-violet visible spectroscopy for metastable zone identification in food and pharmaceutical crystallization processes , 2009 .

[46]  G. Keenan,et al.  The Dimorphism of Sulfathiazole , 1941 .

[47]  Joel Bernstein,et al.  Polymorphism in Molecular Crystals , 2002 .

[48]  M. Kuhnert-Brandstätter,et al.  Polymorphie und Mischkristallbildung bei Sulfonamiden und verwandten Verbindungen , 1969 .

[49]  Allan S. Myerson,et al.  Polymorph Screening: Comparing a Semi-Automated Approach with a High Throughput Method , 2009 .

[50]  Michael B. Hursthouse,et al.  Over one hundred solvates of sulfathiazole , 2001 .